What Cingulate Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 5 |
| Sells | 0 | 0 |
| Total trades | 0 | 15 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 167,068 |
| Disposed | 0 | 14,325 |
| Net activity | +0 | +152,743 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Brams Matthew | EVP and Chief Medical Officer | Mar 09 | Withheld — tax / exercise cost · F | −1,025 | — | — | 8,157 |
| Brams Matthew | EVP and Chief Medical Officer | Mar 09 | Grant / award · A | +4,526 | — | — | 9,182 |
| Callahan Jennifer L. | EVP and CFO | Mar 09 | Withheld — tax / exercise cost · F | −6,427 | — | — | 13,961 |
| Callahan Jennifer L. | EVP and CFO | Mar 09 | Grant / award · A | +15,329 | — | — | 20,388 |
| Schaffer Shane J. | Chief Executive Officer | Mar 09 | Withheld — tax / exercise cost · F | −2,959 | — | — | 4,076 |
| Schaffer Shane J. | Chief Executive Officer | Mar 09 | Grant / award · A | +6,862 | — | — | 7,035 |
| Silva Raul R. | EVP and CSO | Mar 09 | Withheld — tax / exercise cost · F | −1,828 | — | — | 4,645 |
| Silva Raul R. | EVP and CSO | Mar 09 | Grant / award · A | +4,526 | — | — | 6,473 |
| Patel Nilay Dahyabhai | EVP, CLO and CCO | Mar 09 | Withheld — tax / exercise cost · F | −2,086 | — | — | 3,389 |
| Patel Nilay Dahyabhai | EVP, CLO and CCO | Mar 09 | Grant / award · A | +5,475 | — | — | 5,475 |
| Hargroves Thomas Jeffrey | Director | Feb 13 | Open-market buy · P | +97,276 | $5.04 | +$490K | 97,468 |
| Brams Matthew | EVP and Chief Medical Officer | Feb 06 | Open-market buy · P | +1,946 | $5.04 | +$9.81K | 4,656 |
| Schaffer Shane J. | Chief Executive Officer | Feb 06 | Open-market buy · P | +6,809 | $5.04 | +$34.3K | 10,175 |
| Werth Peter J. | Director | Feb 06 | Open-market buy · P | +19,455 | $5.04 | +$98.1K | 117,449 |
| Callahan Jennifer L. | SVP and CFO | Feb 06 | Open-market buy · P | +4,864 | $5.04 | +$24.5K | 5,059 |
| Myers Laurie | EVP and COO | Aug 15 | Open-market sale · S | −202 | $4.17 | −$841 | 0 |
| Werth Peter J. | Director | Apr 11 | Exercise / conversion · M | +694,096 | $0.00 | +$69.4 | 1,175,925 |
| Werth Peter J. | Director | Apr 11 | Exercise / conversion · M | +341,912 | $0.00 | +$684 | 481,829 |
| Callahan Jennifer L. | Corporate Controller | Sep 15 | Open-market buy · P | +5,000 | $0.67 | +$3.35K | 45,508 |
| Werth Peter J. | Director | Aug 11 | Open-market buy · P | +1,823,155 | $0.55 | +$1M | 2,798,320 |
Loading...
